1910 Genetics Debuts with $26M to Accelerate the Design of Small Molecule and Protein Therapeutics Through AI, Computation and Biological Automation
23 mars 2021 09h00 HE
|
1910 Genetics
CAMBRIDGE, Mass., March 23, 2021 (GLOBE NEWSWIRE) -- 1910 Genetics, a biotechnology company integrating artificial intelligence (AI), computation and biological automation to improve drug...